You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication.
The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Cancers, MDPI's open access oncology journal, has published more than 1'000 articles and reviews since its inception in 2009. Cancers is now covered in the Science Citation Index Expanded in Web of Science; the journal is expected to receive its first Impact Factor in the 2017 edition of the Journal Citation Reports, which is going to be published by Clarivate Analytics in June 2018.
Cancers' current CiteScore in Scopus is 5.02. The CiteScore is a ratio between the number of citations in 2016 to papers published 2013–2015 in the numerator and the number of papers published 2013–2015 in the denominator, drawn from Scopus data. Full-text article pages were accessed more than 7'000 times directly from PubMed in August and September 2017.
Our sincere thanks go to the Editors of Cancers, Prof. Dr. Samuel C. Mok and Prof. Dr. David Wong, as well as numerous Guest Editors of Special Issues, who ensure the continued significance of the journal.